BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2047691)

  • 1. Screening for chemical inhibitors of growth rate, encystment, and excystment in Acanthamoeba castellanii.
    Tomlinson G
    Rev Infect Dis; 1991; 13 Suppl 5():S436-7. PubMed ID: 2047691
    [No Abstract]   [Full Text] [Related]  

  • 2. Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility.
    Khunkitti W; Lloyd D; Furr JR; Russell AD
    J Infect; 1998 Jan; 36(1):43-8. PubMed ID: 9515667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects of the cell cycle and encystment of Acanthamoeba.
    Byers TJ; Kim BG; King LE; Hugo ER
    Rev Infect Dis; 1991; 13 Suppl 5():S373-84. PubMed ID: 2047666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disinfection efficacy and encystment rate of soft contact lens multipurpose solutions against Acanthamoeba.
    Lonnen J; Heaselgrave W; Nomachi M; Mori O; Santodomingo-Rubido J
    Eye Contact Lens; 2010 Jan; 36(1):26-32. PubMed ID: 20009947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions.
    Aksozek A; McClellan K; Howard K; Niederkorn JY; Alizadeh H
    J Parasitol; 2002 Jun; 88(3):621-3. PubMed ID: 12099437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acanthamoeba castellanii: A new high-throughput method for drug screening in vitro.
    Ortega-Rivas A; Padrón JM; Valladares B; Elsheikha HM
    Acta Trop; 2016 Dec; 164():95-99. PubMed ID: 27609636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga.
    Schuster FL; Jacob LS
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1263-71. PubMed ID: 1416825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-amoebic properties of carbonyl thiourea derivatives.
    Ibrahim MA; Yusof MS; Amin NM
    Molecules; 2014 Apr; 19(4):5191-204. PubMed ID: 24759076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of diamidines on intracellular polyamines of Acanthamoeba polyphaga.
    Ogbunude PO; Asiri SA
    Drugs Exp Clin Res; 2001; 27(4):127-33. PubMed ID: 11822222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Development of Drugs against Acanthamoeba Infections.
    Siddiqui R; Aqeel Y; Khan NA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6441-6450. PubMed ID: 27600042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba.
    McBride J; Ingram PR; Henriquez FL; Roberts CW
    J Clin Microbiol; 2005 Feb; 43(2):629-34. PubMed ID: 15695656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba.
    Osato MS; Robinson NM; Wilhelmus KR; Jones DB
    Rev Infect Dis; 1991; 13 Suppl 5():S431-5. PubMed ID: 2047690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro study of propamidine isethionate: value in the follow-up of Acanthamoeba amebic keratitis].
    Paniagua-Crespo E; Hasle DP; Aouizerate F; Volant A; Simitzis-Le Flohic AM
    J Fr Ophtalmol; 1989; 12(6-7):489-91. PubMed ID: 2636245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional studies of histidine biosynthesis in Acanthamoeba spp. demonstrates a novel molecular arrangement and target for antimicrobials.
    Rice CA; Campbell SJ; Bisson C; Owen HJ; Sedelnikova SE; Baker PJ; Rice DW; Henriquez FL; Roberts CW
    PLoS One; 2018; 13(7):e0198827. PubMed ID: 29969448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential metabolic targets in chemotherapy for Acanthamoeba infections: polyamine metabolism.
    Shukla OP; Kishore P; Gupta S; Srivastava DK
    Rev Infect Dis; 1991; 13 Suppl 5():S438. PubMed ID: 2047692
    [No Abstract]   [Full Text] [Related]  

  • 17. Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates.
    Kilvington S; Hughes R; Byas J; Dart J
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2007-9. PubMed ID: 12019127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Characterization of an Adrenergic Signalling System Involved in the Encystment of the Ocular Pathogen Acanthamoeba spp.
    Heaselgrave W; Kilvington S
    J Eukaryot Microbiol; 2016 Sep; 63(5):629-34. PubMed ID: 26941040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and expression of a cyst specific protein of Acanthamoeba castellanii.
    Hirukawa Y; Nakato H; Izumi S; Tsuruhara T; Tomino S
    Biochim Biophys Acta; 1998 May; 1398(1):47-56. PubMed ID: 9602053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combating Acanthamoeba spp. cysts: what are the options?
    Anwar A; Khan NA; Siddiqui R
    Parasit Vectors; 2018 Jan; 11(1):26. PubMed ID: 29316961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.